PAM
EPZM

Princeton Alpha Management’s Epizyme, Inc EPZM Stock Holding History

Princeton Alpha Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,058
Closed -$146K – 1012
2016
Q1 		$146K Buy
+12,058
New +$122K 0.02% 666

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Princeton Alpha Management's EPZM Position: Q2 2016 in Review

Princeton Alpha Management sold out of Epizyme, Inc (EPZM) in Q2 2016, closing a stake of 12,058 shares — an estimated $146K sold.

Princeton Alpha Management first reported a position in EPZM in Q1 2016 and held it in 1 quarter. The position peaked at $146K in Q1 2016. 99 funds tracked by Wall St. Rank hold EPZM as of Q2 2016.

  • Princeton Alpha Management reported no remaining Epizyme, Inc position as of Q2 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 12,058 Epizyme, Inc shares in Q2 2016, an estimated $146K.
  • Princeton Alpha Management first reported a position in Epizyme, Inc in Q1 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Epizyme, Inc position peaked at $146K in Q1 2016.
  • 99 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2016.

Based on Princeton Alpha Management's 13F filing for Q2 2016, filed 5 Aug 2016.